Why Choose Medinol?

The Medinol Group is Dedicated to the Science of Cardiovascular Intervention



Ridaforolimus Eluting Coronary Stent System. Optimized stent deliverability and conformability with a metal spring tip.



Ridaforolimus Eluting Coronary Stent System. Redefining stent deliverability and visibility for fast and accurate implantation. EluNIR-PERL is pending CE mark approval.

Pipeline products

Our uncompromising devotion to clinical achievement powers the creation of our products.

Medinol has a wide range of products in the pipeline including Coronary Stents Systems, Structural Heart and Microtech Sensors. (Medinol.com)

Our partner Medinol group

Backed by over 400 patents, the company has delivered over 2,000,000 stents to date and its cutting-edge cardiovascular intervention technology continues to demonstrate extraordinary clinical results.

Medinol’s products constantly stretch the limits of innovation; the scientific spirit that led the company to pioneer the revolutionary NIR stent in 1996 still drives its multidisciplinary team today.